Sarcopenia: Molecular Pathways and Potential Targets for Intervention
Open accessThe DOI matches its Crossref record; 114 of the 114 references it cites were found in a registry or an index.
Abstract
Aging is associated with sarcopenia. The loss of strength results in decreased muscle mass and motor function. This process accelerates the progressive muscle deterioration observed in older adults, favoring the presence of debilitating pathologies. In addition, sarcopenia leads to a decrease in quality of life, significantly affecting self-sufficiency. Altogether, these results in an increase in economic resources from the National Health Systems devoted to mitigating this problem in the elderly, particularly in developed countries. Different etiological determinants are involved in the progression of the disease, including: neurological factors, endocrine alterations, as well as nutritional and lifestyle changes related to the adoption of more sedentary habits. Molecular and cellular mechanisms have not been clearly characterized, resulting in the absence of an effective treatment for sarcopenia. Nevertheless, physical activity seems to be the sole strategy to delay sarcopenia and its symptoms. The present review intends to bring together the data explaining how physical activity modulates at a molecular and cellular level all factors that predispose or favor the progression of this deteriorating pathology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Despite the fact that the effect of Ang-(1-7) has not been directly assayed in SO, the mechanisms involved in muscle mass regulation include decreased protein degradation, prevention of Os, apoptosis, and mitochondrial dysfunction.”
From The critical role of oxidative stress in sarcopenic obesity (2021) · cites this paper as [146]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nitric oxide: physiology, pathophysiology, and pharmacology.
Moncada, S., Palmer, R. M., & Higgs, E. A. (1991) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06663-3 · Cited by 15,525
Sarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afy169 · Cited by 13,818 · cited 1×
“Therefore, sarcopenia appears at a moment in life when physical activity decreases considerably [16], which could be one of the main triggers for the aforementioned events.”
BackgroundSarcopenia: European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Baeyens, J. P., Bauer, J. M., Boirie, Y., Cederholm, T., Landi, F., Martin, F. C., Michel, J.-P., Rolland, Y., Schneider, S. M., et al. (2010) · Age and Ageing · doi:10.1093/ageing/afq034 · Cited by 11,601 · cited 4×
“Furthermore, this degenerative process can exacerbate other underlying conditions, and ultimately cause a decrease in life expectancy [2,3].”
BackgroundInfluentialMassagué, J. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.753 · Cited by 7,556 · cited 2×
“In the case of myostatin, its activation requires the participation of ActRIIB (activin receptor IIB) and ALK4 (activin-like kinase 4), both of which are also involved in activin signaling [36].”
BackgroundCruz-Jentoft, A. J., & Sayer, A. A. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31138-9 · Cited by 3,905
Sarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afz046 · Cited by 3,803
Fielding, R. A., Vellas, B., Evans, W. J., Bhasin, S., Morley, J. E., Newman, A. B., Abellan van Kan, G., Andrieu, S., Bauer, J., Breuille, D., et al. (2011) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2011.01.003 · Cited by 3,256 · cited 1×
“Changes are observed both in fiber size and number, particularly type II fibers [17].”
BackgroundSandri, M., Sandri, C., Gilbert, A., Skurk, C., Calabria, E., Picard, A., Walsh, K., Schiaffino, S., Lecker, S. H., & Goldberg, A. L. (2004) · Cell · doi:10.1016/s0092-8674(04)00400-3 · Cited by 3,012 · cited 1×
“Alterations in the transcriptional regulation at the myocyte level have been proposed, triggering the activation of proteolytic processes [30].”
BackgroundExercise-Induced Oxidative Stress: Cellular Mechanisms and Impact on Muscle Force Production
Powers, S. K., & Jackson, M. J. (2008) · Physiological Reviews · doi:10.1152/physrev.00031.2007 · Cited by 2,459 · cited 13×
“Since this response is mitigated in aged muscle tissue, we can hypothesize that the overproduction of RONS together with a decreased response from antioxidant systems could contribute to the appearance of sarcopenia and delay of muscle regeneration in the elderly [52].”
BackgroundInfluentialPeroxynitrite: biochemistry, pathophysiology and development of therapeutics
Szabó, C., Ischiropoulos, H., & Radi, R. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2222 · Cited by 2,134
Cited by
Items 101–125 of 125
Comparison of methods for diagnosing sarcopenia in patients with rheumatoid arthritis
Stoika, I., Yatsyshyn, R., Drohomeretska, O. I., Popadynets, I., Бабенко, О. І., & Shapoval, O. (2024) · PAIN JOINTS SPINE · doi:10.22141/pjs.14.1.2024.408
The cross-talk between autoimmune diseases and sarcopenia (Preprint)Preprint
Gao, Y., Zhang, Y., Wu, Q., Chen, Q., Wang, Y., Li, B., Zhao, Q., Wang, Q., Wang, Y., & Han, S. (2024) · doi:10.2196/preprints.64456
Prevalence, associated factors and impact of vitamin B12 deficiency in elderly medical inpatientsPreprint
Papakitsou, I., Papazachariou, A., & Filippatos, T. D. (2024) · Research Square · doi:10.21203/rs.3.rs-4744651/v1
New research progress of sarcopenia in surgically resectable malignant tumor diseases
Fu, B., Hu, L., Ji, H., & Hou, Y.-F. (2025) · World Journal of Clinical Oncology · doi:10.5306/wjco.v16.i4.100309
Geriatric care in context of clinical medicine and homeopathy
Bose, R., & Mandal, S. (2025) · International Journal of Homoeopathic Sciences · doi:10.33545/26164485.2025.v9.i2.a.1470
“Additionally, the body's ability to respond to physiological stress declines, further contributing to increased vulnerability in older adults [6, 7] .”
Guzman, M. G. D., Cruz, V. M. P., & Rosales, R. L. (2025) · Journal of Medicine University of Santo Tomas · doi:10.35460/2546-1621.2025-0013
“[6] The potential benefits of nutraceuticals and herbal medicines for the prevention and treatment of sarcopenia have been explored in recent years.”
Li, H.-C., Livneh, H., Chang, W., Wang, Y., Yeh, M.-H., Chen, B.-C., Lu, M., Chen, W. J., & Tsai, T. (2025) · World Journal of Psychiatry · doi:10.5498/wjp.v15.i11.110746
Śliwowski, J., Wojszel, A., Rentflejsz, J., Rogalska, J., Brzoska, M. M., & Wojszel, Z. B. (2025) · Nutrients · doi:10.3390/nu17213413 · Cited by 1
“Skeletal muscles are characterized by a high metabolic rate and are therefore particularly susceptible to damage and dysfunction associated with oxidative stress [13,41,42].”
Sarcopenia modelling by portal vein ligation inducing hyperammonemia in rats
Nadinskaia, M. Y., Александровна, Г. К., Sukhinin, A., Sedova, A., Boykova, P., Izmailov, I. Y., Pokidova, K., Kuzmin, E. A., Venediktov, A. A., Meglinski, I. V., et al. (2025) · PLoS ONE · doi:10.1371/journal.pone.0337178
“A decreased production of short-chain fatty acids by intestinal bacteria, which can affect the synthesis of muscle fibers, may decrease, as well as an imbalance between bacteria producing pro-and anti-inflammatory cytokines also leads to a damaging catabolic impact on muscle fibers [77–79].”
Hu, Z., Tian, Y., Song, X., Zeng, F., & Yang, A. (2022) · Figshare · doi:10.6084/m9.figshare.20625076
Huang, H.-J., Chen, P.-F., Yen, C.-T., Lu, M.-C., Chen, W.-J., & Tsai, T. (2026) · Medicina · doi:10.3390/medicina62010161
The Muscle Function Deficit Concept and Inflammaging
Mariano, G., Candeloro, M., Pellegrino, R., Paganelli, R., & Iorio, A. D. (2026) · Biomedicines · doi:10.3390/biomedicines14020383 · Cited by 1
“Importantly, declines in muscle function, rather than loss of muscle mass per se, are the primary determinants of reduced quality of life, loss of independence, and impaired self-sufficiency in older adults [7,8].”
Yan, H. C., Chai, Y., Zhang, Y., Zhan, Y., Rong, J., Song, Y., & Yuan, W. (2026) · BMC Geriatrics · doi:10.1186/s12877-026-07191-6
“Considering the potential reversibility of sarcopenia [12, 13], early screening and diagnosis are imperative to implement effective interventions.”
López, R. L., Cruz, A. C., & Victoria, L. E. J. (2025) · Revista Mexicana de Medicina Física y Rehabilitación · doi:10.35366/122517
Israr, M., Shah, Z., Malik, O., & Ahmad, F. (2026) · Khyber Journal Of Medical Sciences · doi:10.70520/kjms.v19i1.772
Yang, J., Zhou, K., He, X., & Rong, K. (2026) · Experimental Gerontology · doi:10.1016/j.exger.2026.113150
黄, 金. (2026) · Hans Journal of Food and Nutrition Science · doi:10.12677/hjfns.2026.153026
Ramos-Hernández, R., Pascual-Fernández, J., Álvarez-Pardo, S., Fernández‐Lázaro, D., Martínez‐Ferrán, M., Busto, N., & Mielgo‐Ayuso, J. (2026) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2026.103356
Self-citationPerspective Chapter: The Strategy of Motivation Technique in Sarcopenia Prevention
Istifanus, D. K. (2026) · IntechOpen eBooks · doi:10.5772/intechopen.1005874
Ding, Y., Zhu, J., He, Y., Yang, X., Liang, W., Yang, K., Wu, X., Li, G., Zhao, J., Zhao, Z., et al. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2026.1837086
Wang, J., & Li, J. (2026) · Biochemical Genetics · doi:10.1007/s10528-026-11418-x
“To truly understand how exercise counteracts sarcopenia, it is essential to consider this interplay and, most importantly, to ground these molecular mecha - nisms in the evidence from human clinical trials (Pascual-Fernández et al. 2020 ).”
Lee, J., Chun, S.-W., Choi, S., Kang, J. S., Park, S. J., Yang, Y. R., Lee, H., & Lee, K.-H. (2026) · Journal of sport and health science/Journal of Sport and Health Science · doi:10.1016/j.jshs.2026.101159
Imeglimin Attenuates Skeletal Muscle Atrophy in Mouse Models of Obesity and Ageing
Ye, Y., Qian, D., Nomura, I., Kobayashi, N., Shimizu, Y., Okamura, T., Awazawa, M., & Ueki, K. (2026) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.70354
Xu, J., Li, S., Yang, X., & Mao, D. (2026) · Experimental Gerontology · doi:10.1016/j.exger.2026.113264 · Cited by 2
Kumar, H. V. S., Choudhury, D., Lei, P., Mehrotra, P., Shahini, S., Swedick, S., Toftegaard, J., & Andreadis, S. T. (2026) · Aging Cell · doi:10.1111/acel.70703
Metadata
- Authors
- Pascual-Fernández, J., Fernández-Montero, A., Córdova-Martínez, A., Pastor, D., Martínez-Rodríguez, A., & Roche, E.
- Affiliations
- Medical Extrahospital Emergency Service of Navarra, 31500 Pamplona, Spain
- Prevention and Health Service, University Clinic of Navarra, 31008 Pamplona, Spain
- Biochemistry, Molecular Biology and Physiology, Faculty of Health Sciences, GIR Physical Exercise and Aging, University of Valladolid, Campus Duques de Soria, 42004 Soria, Spain
- Universitat de Miguel Hernández d'Elx (ES)
- University of Alicante (ES)
- Corresponding author
- Roche, Enrique
- ORCID
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-11-22
- Volume
- 21
- Issue
- 22
- Pages
- 8844
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC7700275
- OpenAlex
- W3108240984
- Cited by
- 125
- References
- 112
- Citations by year
- 2026: 24 · 2025: 24 · 2024: 24 · 2023: 23 · 2022: 20 · 2021: 10
- FWCI
- 1.69
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- University of Valladolid Documentary Repository (University of Valladolid) (submittedVersion, cc-by)
- Deposito Adademico Digital Universidad De Navarra (University of Navarra) (submittedVersion, cc-by)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Repositorio Institucional de la Universidad de Alicante (Universidad de Alicante) (submittedVersion, cc-by)
- Funders
- ISABIAL (190290)
- Institute of Health Carlos III (CB12/03/30038)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Health Sciences › Nursing › Nutrition and Dietetics › Muscle metabolism and nutrition
- Keywords
- sarcopenia, aging, muscle mass loss, muscle strength, physical activity, molecular pathways, cellular mechanisms, endocrine alterations, dietary factors, sedentary lifestyle, intervention targets, older adults
- MeSH terms
- Aging, Humans, Inflammation, Signal Transduction, Oxidative Stress, Muscle, Skeletal, Sarcopenia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.